Ameetee: Revolutionizing B2B Securities Trading

A fintech startup called Ameetee has raised a $1 million seed round to introduce the first B2B fintech platform that gives financial institutions an all-in solution to offer their clients transferable securities as an investment in private enterprises. The site has generated $12 million in revenue since its introduction in 2023. Ameetee has inked contracts with multiple institutional clients and provided investment possibilities in businesses like Alto Pharmacy, Klarna, and Bayzat.

The money was provided by a group of business angels, which included Jamie Karraker, the creator of the unicorn Alto Pharmacy. It will be used to create a market place where these securities can be traded as well as the first training program for bankers and brokers who are not familiar with investing in private businesses.

Ameetee is the first company to democratize access to shares of private companies and other assets from the private market. This company targets financial institutions rather than individuals and was founded by a group of investment professionals with 15 to 20 years of experience apiece, including Mila Khrapchenko, a business angel and investor in TechAviv fund.

Ameetee concentrates its efforts on growing the fintech market's FaaS (Fintech-as-a-Service) segment, which is expected to rise significantly and reach $949 billion by 2030. The rising demand for digital financial services and the merging of cutting-edge fintech startups with established financial institutions are credited with this expansion.